Landscapes

X-Linked Lymphoproliferative Syndrome 2

1 drug in active X-Linked Lymphoproliferative Syndrome 2 trials · Updated 18 Nov 2026

Furthest along
1 in Phase 2
Next Phase 3 result
None yet
Drugs
1
In active trials, any stage
Trials
1 active
No sub-diseases

Drugs1

DrugHow it worksCompanyStageNext dateDetails
Multi-specific immunoglobulin
Phase 2 —

How trials write it1

The conditions trials list that we place on X-Linked Lymphoproliferative Syndrome 2 itself, with their active trials

NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations 1

About

Summary
1 drug is in active X-Linked Lymphoproliferative Syndrome 2 trials. Updated 18 Nov 2026.
Registry term
Lymphoproliferative Syndrome, X-Linked, 2
Counts
Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
Sources
ClinicalTrials.gov updated 18 Nov 2026